These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18058084)

  • 1. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
    Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
    Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane.
    Tamsma JT; van den Born J; Bruijn JA; Assmann KJ; Weening JJ; Berden JH; Wieslander J; Schrama E; Hermans J; Veerkamp JH
    Diabetologia; 1994 Mar; 37(3):313-20. PubMed ID: 8174847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
    van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ
    Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
    van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
    Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
    van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
    Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
    An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
    Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of heparanase in diseases of the glomeruli.
    Szymczak M; Kuźniar J; Klinger M
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):45-56. PubMed ID: 20049646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
    Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
    Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of heparanase in overt diabetic nephropathy.
    van den Hoven MJ; Rops AL; Bakker MA; Aten J; Rutjes N; Roestenberg P; Goldschmeding R; Zcharia E; Vlodavsky I; van der Vlag J; Berden JH
    Kidney Int; 2006 Dec; 70(12):2100-8. PubMed ID: 17051139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of human heparanase in the pathogenesis of diabetic nephropathy.
    Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I
    Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
    Kramer A; van den Hoven M; Rops A; Wijnhoven T; van den Heuvel L; Lensen J; van Kuppevelt T; van Goor H; van der Vlag J; Navis G; Berden JH
    J Am Soc Nephrol; 2006 Sep; 17(9):2513-20. PubMed ID: 16899518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients.
    Maxhimer JB; Somenek M; Rao G; Pesce CE; Baldwin D; Gattuso P; Schwartz MM; Lewis EJ; Prinz RA; Xu X
    Diabetes; 2005 Jul; 54(7):2172-8. PubMed ID: 15983219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
    Lewis EJ; Xu X
    Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.
    Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J
    Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase in Kidney Disease.
    van der Vlag J; Buijsers B
    Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary heparanase activity in patients with Type 1 and Type 2 diabetes.
    Rops AL; van den Hoven MJ; Veldman BA; Salemink S; Vervoort G; Elving LD; Aten J; Wetzels JF; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2012 Jul; 27(7):2853-61. PubMed ID: 22187315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium.
    Yard BA; Kahlert S; Engelleiter R; Resch S; Waldherr R; Groffen AJ; van den Heuvel LP; van der Born J; Berden JH; Kröger S; Hafner M; van der Woude FJ
    Exp Nephrol; 2001; 9(3):214-22. PubMed ID: 11340306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells.
    Masola V; Gambaro G; Tibaldi E; Onisto M; Abaterusso C; Lupo A
    Biochim Biophys Acta; 2011 Aug; 1813(8):1475-82. PubMed ID: 21600934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
    Wijnhoven TJ; Geelen JM; Bakker M; Lensen JF; Rops AL; Kramer AB; Navis G; van den Hoven MJ; van der Vlag J; Berden JH; Wetzels JF; van den Heuvel LP; Monnens LA; van Kuppevelt TH
    Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
    Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
    J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.